共 95 条
[1]
Freifeld AG(2011)Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America Clin Infect Dis 52 427-431
[2]
Bow EJ(2013)Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline J Clin Oncol 31 794-810
[3]
Sepkowitz KA(2006)Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients Cancer 106 2258-2266
[4]
Boeckh MJ(2015)Risk factors for piperacillin/tazobactam-resistant gram-negative infection in hematology/oncology patients with febrile neutropenia Support Care Cancer 23 2287-2295
[5]
Ito JI(2005)Fluoroquinolone resistance of Eur J Clin Microbiol Infect Dis 24 111-118
[6]
Mullen CA(2005) at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia Clin Infect Dis 41 1254-1260
[7]
Flowers CR(2005)Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec N Engl J Med 353 977-987
[8]
Seidenfeld J(2005)Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia N Engl J Med 353 988-998
[9]
Bow EJ(2011)Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas J Thorac Oncol 6 2090-2096
[10]
Karten C(2009)Randomized phase III trial of docetaxel plus carboplatin with or without levofloxacin prophylaxis in elderly patients with advanced non-small cell lung cancer: the APRONTA trial J Biomed Inform 42 377-381